Featured White Papers
- Oct. 14th: Simplified IT with Software-as-a-Service (SaaS) (ZDNet)
- The rise of Web commuting (Citrix Online)
- PCI DSS therapy for the smaller retailer (McAfee)
Health Care Industry
Industry: Email Alert RSS FeedAcute Management of Atrial Fibrillation: Part I. Rate and Rhythm Control
American Family Physician, July 15, 2002 by Dana E. King, Lori M. Dickerson, Jonathan L. Sack
(11.) Schreck DM, Rivera AR, Tricarico VJ. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin. Ann Emerg Med 1997;29:135-40.
(12.) Segal JB, McNamara RL, Miller MR, Kim N, Goodman SN, Powe NR, et al. The evidence regarding the drugs used for ventricular rate control. J Fam Pract 2000;49:47-59.
(13.) Falk RH, Leavitt JI. Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med 1991; 114:573-5.
(14.) Rich MW. Heart failure. Cardiol Clin 1999;17:123-35.
(15.) Farshi R, Kistner D, Sarma JS, Longmate JA, Singh BN. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol 1999;33:304-10.
(16.) Masoudi FA, Goldschlager N. The medical management of atrial fibrillation. Cardiol Clin 1997; 15:689-719.
(17.) Miller MR, McNamara RL, Segal JB, Kim N, Robinson KA, Goodman SN, et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. J Fam Pract 2000;49:1033-46.
(18.) Wyse DG. The AFFIRM trial: main trial and substudies--what can we expect? J Interv Card Electrophysiol 2000;4(suppl 1):171-6.
(19.) Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000;356:1789-94.
(20.) Michael JA, Stiell IG, Agarwal S, Mandavia DP. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med 1999;33: 379-87.
(21.) Camm AJ. Atrial fibrillation: is there a role for low-molecular-weight heparin? Clin Cardiol 2001;24(3 suppl):I15-9.
(22.) Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-20.
COPYRIGHT 2002 American Academy of Family Physicians
COPYRIGHT 2002 Gale Group
